Xiaonan Tang
State Key Laboratory Of Digestive Health, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic effects of coptisine derivative EHLJ7 on colorectal cancer by inhibiting PI3K/AKT pathway.
Journal: Cellular signalling
Published: September 19, 2023
IGFBP7 overexpression promotes acquired resistance to AZD9291 in non-small cell lung cancer.
Journal: Biochemical and biophysical research communications
Published: June 23, 2021
CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 29, 2021
CS-semi5 Inhibits NF-κB Activation to Block Synovial Inflammation, Cartilage Loss and Bone Erosion Associated With Collagen-Induced Arthritis.
Journal: Frontiers in pharmacology
Published: January 18, 2021
HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial-Mesenchymal Transition.
Journal: Drug design, development and therapy
Published: May 28, 2020
Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway.
Journal: Frontiers in pharmacology
Published: July 11, 2019
Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 18, 2017
Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB Pathway.
Journal: Frontiers in pharmacology
Published: May 10, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026